31 Shocking GLP-1 Side Effects That Have Nothing To Do With Weight Loss
8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Evidence dossier
Intelligence passport
Measured timeline
What happened
- Velocity & Diffusion: Coverage exploded across 8 distinct news outlets with 8 published articles, achieving a live velocity of 6.
- Primary Driver: 8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"31 Shocking GLP-1 Side Effects That Have Nothing To Do With Weight Loss" is generating significant coverage in the Health category, with 8 articles from 8 distinct sources tracked by Archynetys so far.
Outlets currently covering the story include Psychology Today, News-Medical, Psychiatric Times and MIT Technology Review. Archynetys measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
Synthesized from multi-source international reporting and live coverage telemetry under Archynetys open intelligence methodology.
Generated by Archynetys's extractive engine from coverage metadata only — no AI-written claims. Updated 3h ago.
The reporting (8)
-
GLP-1 Drugs and Eating Disorders: What Experts RecommendPsychology Today · 1d ago
-
-
GLP-1 Receptor Agonists May Reinforce Restriction in Patients With Eating DisordersPsychiatric Times · 1d ago
-
Eating disorders are on the rise. GLP-1s could make things worse.MIT Technology Review · 1d ago
-
-
Most GLP-1 Users Gain Weight After Stopping TreatmentAthletech News · 1d ago
-
The Generation Actually Using GLP-1s the Most: Survey Shows Generational DifferencesEveryday Health · 1d ago
-
Questions people are asking
Why is "31 Shocking GLP-1 Side Effects That Have Nothing To Do With Weight Loss" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst Archynetys classifies as a trend.
How does Archynetys measure this trend?
Archynetys scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Topics
Related trends
Advanced Metrics That Give BYU the Upper Hand Against Arizona State
11 news sources are covering this Sports story right now — Archynetys is tracking how fast it spreads.
The Risky Trade That Changed the Brewers and Delivered an Improbable Championship
7 news sources are covering this Sports story right now — Archynetys is tracking how fast it spreads.
Inside the Rays’ 12th-Inning Rally That Canceled the Brewers’ Championship Celebration. At Least for Now
6 news sources are covering this Sports story right now — Archynetys is tracking how fast it spreads.
Earnings live updates: Eli Lilly stock pops as strong GLP-1 drug demand lifts results, ServiceNow stock plunges
Eli Lilly stock surges as GLP-1 drug demand outpaces expectations, ServiceNow shares plummet 24%.
Receive a Spewpa That Can Evolve into a Random Vivillon Pattern in Pokémon Legends: Z‑A
10 news sources are covering this Technology story right now — Archynetys is tracking how fast it spreads.
Weight-loss drugs linked to these deficiencies reported by users, research reveals
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.